Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Haas

Showing results (151-160 of 209) with videos related to

Pageof 21
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004
Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriersDaniel S Warren, Andrea A Zachary, Christopher J Sonnenday, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 31, 2025
Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?Valentina Querin, Leonardo Palazzo, Agnes B Fogo, et al.
Kidney International|February 3, 2012
Pros and cons for C4d as a biomarkerDanielle Cohen, Robert B Colvin, Mohamed R Daha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr miceLihua Bao, Mark Haas, Susan A Boackle, et al.
Journal of the American Society of Nephrology : JASN|July 9, 2015
The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic LesionsSuzanne Wilhelmus, Charles E Alpers, H Terence Cook, et al.
Transplantation|May 29, 2015
A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize PatientsAshley A Vo, Jua Choi, Irene Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2010
B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failurePatrizia Farci, Giacomo Diaz, Zhaochun Chen, et al.
Pediatric Transplantation|September 21, 2017
Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipientsIrene K Kim, Jua Choi, Ashley Vo, et al.
Transplantation|October 30, 2010
Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patientsNancy L Reinsmoen, Chih-Hung Lai, Harald Heidecke, et al.
Archives of Pathology & Laboratory Medicine|January 10, 2008
Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsiesMark Haas, Dorry L Segev, Lorraine C Racusen, et al.
Pageof 21

Showing results (151-160 of 209) with videos related to

Sort By:
Pageof 21
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|March 17, 2004
Successful renal transplantation across simultaneous ABO incompatible and positive crossmatch barriersDaniel S Warren, Andrea A Zachary, Christopher J Sonnenday, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 31, 2025
Biomarkers of Lupus Nephritis Histopathology: Where Do We Stand?Valentina Querin, Leonardo Palazzo, Agnes B Fogo, et al.
Kidney International|February 3, 2012
Pros and cons for C4d as a biomarkerDanielle Cohen, Robert B Colvin, Mohamed R Daha, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 22, 2002
Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr miceLihua Bao, Mark Haas, Susan A Boackle, et al.
Journal of the American Society of Nephrology : JASN|July 9, 2015
The Revisited Classification of GN in SLE at 10 Years: Time to Re-Evaluate Histopathologic LesionsSuzanne Wilhelmus, Charles E Alpers, H Terence Cook, et al.
Transplantation|May 29, 2015
A Phase I/II Trial of the Interleukin-6 Receptor-Specific Humanized Monoclonal (Tocilizumab) + Intravenous Immunoglobulin in Difficult to Desensitize PatientsAshley A Vo, Jua Choi, Irene Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2010
B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failurePatrizia Farci, Giacomo Diaz, Zhaochun Chen, et al.
Pediatric Transplantation|September 21, 2017
Risk factors for the development of antibody-mediated rejection in highly sensitized pediatric kidney transplant recipientsIrene K Kim, Jua Choi, Ashley Vo, et al.
Transplantation|October 30, 2010
Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patientsNancy L Reinsmoen, Chih-Hung Lai, Harald Heidecke, et al.
Archives of Pathology & Laboratory Medicine|January 10, 2008
Arteriosclerosis in kidneys from healthy live donors: comparison of wedge and needle core perioperative biopsiesMark Haas, Dorry L Segev, Lorraine C Racusen, et al.
Pageof 21